Belimumab Intravenous and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Belimumab Intravenous and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: belimumab
Brand name: Benlysta, Benlysta Autoinjector
Synonyms: Belimumab
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Belimumab Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Belimumab Intravenous-Kitabis Pak
- Belimumab Intravenous-Kitabis Pak inhalation
- Belimumab Intravenous-Klofensaid II
- Belimumab Intravenous-Klonopin
- Belimumab Intravenous-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Belimumab Vials
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Belinostat
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Belinostat Intravenous
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Belladonna
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Belladonna alkaloids and phenobarbital
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Belladonna and Opium